Daniel S. Reshef
28 works · 2,737 citations · h-index 8
Top works
- Fulminant Myocarditis with Combination Immune Checkpoint Blockade
- Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis
- Diagnosis and intraoperative localization of a deep orbital organic foreign body
- Intraocular Pressure in Eyes Receiving Monthly Ranibizumab in 2 Pivotal Age-Related Macular Degeneration Clinical Trials
- Postoperative cataract surgery satisfaction in a rural Kenyan clinic
- The impact of database restriction on pharmacovigilance signal detection of selected cancer therapies
- Echographic findings in Terson’s syndrome
- Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin
- Diastolic Blood Pressure Levels and Ischemic Stroke Incidence in Older Adults With White Matter Lesions
- Streak retinoscopy during intraocular lens implantation to determine spheric power and prevent astigmatism.
- Acoustic tissue differentiation with Standardized Echography in reference to melanomas and pseudomelanomas
- Safety of weight-based dosing of nivolumab with or without ipilimumab by body mass index (BMI) stratified by sex across 14 CheckMate clinical trials.
- Supplementary Figure 2A from Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin
- Supplementary Figure 1 from Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin
- Following the Heart: The History of the J-Curve in Stroke Risk
- Data from Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin
- Supplementary Figure 3B from Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin
- Author reply
- Supplementary Figure 2B from Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin
- Supplementary Figure Legends 1-3 from Mortality in the Randomized, Controlled Lung Intergroup Trial of Isotretinoin